• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经营养酪氨酸激酶受体(NTRK)融合基因与人乳头瘤病毒感染在宫颈癌进展中的相互作用(综述)

The mutual interplay between NTRK fusion genes and human papillomavirus infection in cervical cancer progression (Review).

作者信息

Aziz Aziz Ur Rehman, Zhang Jianing, Zhang Chan, Yu Xiaohui, Wang Daqing

机构信息

Key Laboratory for Early Diagnosis and Biotherapy of Malignant Tumors in Children and Women, Dalian Women and Children's Medical Group, Dalian, Liaoning 116012, P.R. China.

出版信息

Mol Clin Oncol. 2024 Jul 18;21(4):67. doi: 10.3892/mco.2024.2765. eCollection 2024 Oct.

DOI:10.3892/mco.2024.2765
PMID:39091417
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11289753/
Abstract

Cervical cancer is a significant global health concern, with a substantial portion of cases attributed to human papillomavirus (HPV) infection. Recent advancements in molecular profiling have identified distinct subtypes of cervical cancer based on their genomic alterations. One such subgroup is neurotrophic tropomyosin receptor kinase (NTRK) fusion-positive cervical cancers, characterized by gene fusions involving the NTRK genes. Although both NTRK fusion genes and HPV infections are independently recognized as significant risk factors in cervical cancer, their interplay and mutual effects on cancer progression are not yet fully understood. The present review is the first of its kind to explore the potential interplay between NTRK fusion genes and HPV infections. It surveys in detail how their combined effect can influence the signaling pathways during cervical cancer development and progression. Moreover, the present study discussed the clinical features, histopathological examinations, treatment procedures and follow-up outcomes of NTRK-fusion gene-positive cervical cancer. The present review may help in the understanding of the management and treatment of such rare, lethal and resistant cervical cancers.

摘要

宫颈癌是一个重大的全球健康问题,相当一部分病例归因于人类乳头瘤病毒(HPV)感染。分子图谱分析的最新进展已根据基因组改变确定了宫颈癌的不同亚型。其中一个亚组是神经营养性原肌球蛋白受体激酶(NTRK)融合阳性宫颈癌,其特征是涉及NTRK基因的基因融合。尽管NTRK融合基因和HPV感染均被独立认为是宫颈癌的重要危险因素,但它们在癌症进展中的相互作用和相互影响尚未完全了解。本综述是同类研究中首次探讨NTRK融合基因与HPV感染之间潜在相互作用的研究。它详细调查了它们的联合作用如何影响宫颈癌发生和发展过程中的信号通路。此外,本研究讨论了NTRK融合基因阳性宫颈癌的临床特征、组织病理学检查、治疗程序和随访结果。本综述可能有助于理解此类罕见、致命且耐药的宫颈癌的管理和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc1/11289753/fa067d79cc9d/mco-21-04-02765-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc1/11289753/b1d9497561c3/mco-21-04-02765-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc1/11289753/931104f8b397/mco-21-04-02765-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc1/11289753/d456c5754f1f/mco-21-04-02765-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc1/11289753/95fb27d5efc5/mco-21-04-02765-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc1/11289753/fa067d79cc9d/mco-21-04-02765-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc1/11289753/b1d9497561c3/mco-21-04-02765-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc1/11289753/931104f8b397/mco-21-04-02765-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc1/11289753/d456c5754f1f/mco-21-04-02765-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc1/11289753/95fb27d5efc5/mco-21-04-02765-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc1/11289753/fa067d79cc9d/mco-21-04-02765-g04.jpg

相似文献

1
The mutual interplay between NTRK fusion genes and human papillomavirus infection in cervical cancer progression (Review).神经营养酪氨酸激酶受体(NTRK)融合基因与人乳头瘤病毒感染在宫颈癌进展中的相互作用(综述)
Mol Clin Oncol. 2024 Jul 18;21(4):67. doi: 10.3892/mco.2024.2765. eCollection 2024 Oct.
2
Prevalence of neurotrophic tropomyosin receptor kinase (NTRK) fusion gene positivity in patients with solid tumors in Japan.在日本的实体瘤患者中,神经营养性原肌球蛋白受体激酶(NTRK)融合基因阳性的发生率。
Cancer Med. 2024 Jun;13(12):e7351. doi: 10.1002/cam4.7351.
3
Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population.来自大量真实世界人群的NTRK1/2/3融合阳性肿瘤的基因组背景。
NPJ Precis Oncol. 2021 Jul 20;5(1):69. doi: 10.1038/s41698-021-00206-y.
4
The Use of Pan-Tropomyosin Receptor Kinase Immunohistochemistry as a Screening Tool for the Detection of Neurotrophic Tropomyosin-Related Kinase Fusions: Real-World Data from a National Multicentric Retrospective Study.使用泛原肌球蛋白受体激酶免疫组织化学作为检测神经营养性原肌球蛋白相关激酶融合的筛查工具:一项全国多中心回顾性研究的真实世界数据
Pathobiology. 2022;89(6):393-406. doi: 10.1159/000522426. Epub 2022 Mar 29.
5
TRK Fusion Cancer: Patient Characteristics and Survival Analysis in the Real-World Setting.TRK 融合癌:真实世界环境中的患者特征和生存分析。
Target Oncol. 2021 May;16(3):389-399. doi: 10.1007/s11523-021-00815-4. Epub 2021 Apr 24.
6
EML4-NTRK3 Fusion Cervical Sarcoma: A Case Report and Literature Review.EML4-NTRK3融合性宫颈肉瘤:一例病例报告及文献综述
Front Med (Lausanne). 2022 Apr 28;9:832376. doi: 10.3389/fmed.2022.832376. eCollection 2022.
7
Prognosis and oncogenomic profiling of patients with tropomyosin receptor kinase fusion cancer in the 100,000 genomes project.“十万基因组计划”中肌钙蛋白受体激酶融合癌患者的预后与肿瘤基因组分析
Cancer Treat Res Commun. 2022;33:100623. doi: 10.1016/j.ctarc.2022.100623. Epub 2022 Aug 23.
8
Diagnosis and Management of Tropomyosin Receptor Kinase Fusion-Positive Thyroid Carcinomas: A Review.《棘皮动物微管相关蛋白受体激酶融合阳性甲状腺癌的诊断与治疗:综述》。
JAMA Oncol. 2023 Aug 1;9(8):1132-1141. doi: 10.1001/jamaoncol.2023.1379.
9
NTRK Fusion in Non-Small Cell Lung Cancer: Diagnosis, Therapy, and TRK Inhibitor Resistance.非小细胞肺癌中的NTRK融合:诊断、治疗及TRK抑制剂耐药性
Front Oncol. 2022 Mar 17;12:864666. doi: 10.3389/fonc.2022.864666. eCollection 2022.
10
NTRK fusions in thyroid cancer: Pathology and clinical aspects.甲状腺癌中的NTRK融合:病理学及临床方面
Crit Rev Oncol Hematol. 2023 Apr;184:103957. doi: 10.1016/j.critrevonc.2023.103957. Epub 2023 Mar 11.

引用本文的文献

1
Role of NTRK Fusion Genes in the Tumor Immune Microenvironment of HPV (+/-) Cervical Cancer.NTRK融合基因在人乳头瘤病毒(±)宫颈癌肿瘤免疫微环境中的作用
J Med Virol. 2025 Aug;97(8):e70564. doi: 10.1002/jmv.70564.

本文引用的文献

1
Conservative surgical treatment with fertility preservation in a young adult with rearranged spindle cell neoplasm of the uterine cervix.对一名患有子宫颈梭形细胞肿瘤重排的年轻成年人进行保留生育功能的保守性手术治疗。
Gynecol Oncol Rep. 2023 Jun 24;48:101233. doi: 10.1016/j.gore.2023.101233. eCollection 2023 Aug.
2
NTRK-rearranged uterine sarcoma: A case report.NTRK重排的子宫肉瘤:一例报告。
Asian J Surg. 2023 Nov;46(11):4764-4765. doi: 10.1016/j.asjsur.2023.05.088. Epub 2023 Jun 1.
3
Detection of circulating cell-free HPV DNA of 13 HPV types for patients with cervical cancer as potential biomarker to monitor therapy response and to detect relapse.
检测宫颈癌患者循环游离 HPV DNA 的 13 种 HPV 类型,作为潜在的生物标志物来监测治疗反应和检测复发。
Br J Cancer. 2023 Jun;128(11):2097-2103. doi: 10.1038/s41416-023-02233-x. Epub 2023 Mar 27.
4
NTRK -Rearranged Uterine Sarcomas: Clinicopathologic Features of 15 Cases, Literature Review, and Risk Stratification.NTRK 重排型子宫肉瘤:15 例临床病理特征、文献复习及风险分层。
Am J Surg Pathol. 2022 Oct 1;46(10):1415-1429. doi: 10.1097/PAS.0000000000001929. Epub 2022 Jun 20.
5
EML4-NTRK3 Fusion Cervical Sarcoma: A Case Report and Literature Review.EML4-NTRK3融合性宫颈肉瘤:一例病例报告及文献综述
Front Med (Lausanne). 2022 Apr 28;9:832376. doi: 10.3389/fmed.2022.832376. eCollection 2022.
6
Long-read sequencing unveils high-resolution HPV integration and its oncogenic progression in cervical cancer.长读测序揭示了宫颈癌中 HPV 整合的高分辨率及其致癌进展。
Nat Commun. 2022 May 10;13(1):2563. doi: 10.1038/s41467-022-30190-1.
7
Human Papillomaviruses as Infectious Agents in Gynecological Cancers. Oncogenic Properties of Viral Proteins.人乳头瘤病毒作为妇科癌症的传染性病原体。病毒蛋白的致癌特性。
Int J Mol Sci. 2022 Feb 5;23(3):1818. doi: 10.3390/ijms23031818.
8
Adult NTRK-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements.内脏器官的成人 NTRK 重排梭形细胞肿瘤:重点关注罕见部位和异源成分。
Mod Pathol. 2022 Jul;35(7):911-921. doi: 10.1038/s41379-021-01005-3. Epub 2022 Feb 11.
9
NTRK-Fusion Sarcoma of the Uterine Cervix: Report of 2 Cases With Comparative Clinicopathologic Features.宫颈 NTRK 融合肉瘤:2 例病例的比较临床病理特征报告。
Int J Gynecol Pathol. 2022 Nov 1;41(6):642-648. doi: 10.1097/PGP.0000000000000834. Epub 2021 Oct 29.
10
NTRK insights: best practices for pathologists.NTRK 解读:病理学家的最佳实践
Mod Pathol. 2022 Mar;35(3):298-305. doi: 10.1038/s41379-021-00913-8. Epub 2021 Sep 16.